Latest News about HALO
Recent news which mentions HALO
Earnings Scheduled For May 11, 2026
May 11, 2026
From Benzinga
What 7 Analyst Ratings Have To Say About Halozyme Therapeutics
August 18, 2025
Tickers
HALO
From Benzinga
Earnings Scheduled For August 5, 2025
August 05, 2025
From Benzinga
From Benzinga
Here's How Much You Would Have Made Owning Halozyme Therapeutics Stock In The Last 15 Years
July 07, 2025
From Benzinga
Here's How Much $100 Invested In Halozyme Therapeutics 15 Years Ago Would Be Worth Today
June 12, 2025
From Benzinga
Here's How Much You Would Have Made Owning Halozyme Therapeutics Stock In The Last 5 Years
June 04, 2025
From Benzinga
Price Over Earnings Overview: Halozyme Therapeutics
May 28, 2025
From Benzinga
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
May 24, 2025
From Benzinga
Evolv Technologies, Quantum Computing, ACADIA Pharmaceuticals And Other Big Stocks Moving Higher On Friday
May 16, 2025
From Benzinga
From Benzinga
S&P 500 Breaks Into Positive Territory For 2025
May 13, 2025
From TalkMarkets
Crude Oil Gains 3%; US Inflation Eases In April
May 13, 2025
From Benzinga
From Benzinga
Here's How Much You Would Have Made Owning Halozyme Therapeutics Stock In The Last 15 Years
May 09, 2025
From Benzinga
From Benzinga
Earnings Scheduled For May 6, 2025
May 06, 2025
From Benzinga
Here's How Much You Would Have Made Owning Halozyme Therapeutics Stock In The Last 5 Years
April 22, 2025
From Benzinga
FDA Approves Argenx's Vyvgart Hytrulo Prefilled Syringe For Self-Injection For At Home Use Setting
April 11, 2025
From Benzinga
Peering Into Halozyme Therapeutics's Recent Short Interest
April 11, 2025
Tickers
HALO
From Benzinga
Assessing Halozyme Therapeutics: Insights From 9 Financial Analysts
February 20, 2025
Tickers
HALO
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.